Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy

Stock Information for Nuwellis Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Nuwellis Inc.

Nuwellis Appoints Carisa Schultz as Chief Financial Officer
Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market
Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy
Nuwellis Announces Changes to Board of Directors
Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings
Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.
Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum
Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian(TM) Pediatric System with Advanced Clamp Safety Technology

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.